Annual Accounts Payable
$9.81 M
+$2.30 M+30.63%
December 1, 2024
Summary
- As of February 26, 2025, VKTX annual accounts payable is $9.81 million, with the most recent change of +$2.30 million (+30.63%) on December 1, 2024.
- During the last 3 years, VKTX annual accounts payable has risen by +$8.37 million (+579.57%).
- VKTX annual accounts payable is now at all-time high.
Performance
VKTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$9.81 M
+$9.56 M+3763.39%
December 1, 2024
Summary
- As of February 26, 2025, VKTX quarterly accounts payable is $9.81 million, with the most recent change of +$9.56 million (+3763.39%) on December 1, 2024.
- Over the past year, VKTX quarterly accounts payable has stayed the same.
- VKTX quarterly accounts payable is now -11.51% below its all-time high of $11.09 million, reached on June 30, 2024.
Performance
VKTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
VKTX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.6% | 0.0% |
| 3 y3 years | +579.6% | +579.6% |
| 5 y5 years | +303.7% | +303.7% |
VKTX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +579.6% | -11.5% | +3763.4% |
| 5 y | 5-year | at high | +579.6% | -11.5% | +3763.4% |
| alltime | all time | at high | >+9999.0% | -11.5% | +3763.4% |
Viking Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $9.81 M(+30.6%) | $9.81 M(+3763.4%) |
| Sep 2024 | - | $254.00 K(-97.7%) |
| Jun 2024 | - | $11.09 M(+112.2%) |
| Mar 2024 | - | $5.22 M(-30.4%) |
| Dec 2023 | $7.51 M(-11.9%) | $7.51 M(+31.5%) |
| Sep 2023 | - | $5.71 M(+1.8%) |
| Jun 2023 | - | $5.61 M(+47.7%) |
| Mar 2023 | - | $3.80 M(-55.5%) |
| Dec 2022 | $8.53 M(+490.7%) | $8.53 M(+171.5%) |
| Sep 2022 | - | $3.14 M(-48.5%) |
| Jun 2022 | - | $6.10 M(+95.7%) |
| Mar 2022 | - | $3.12 M(+116.0%) |
| Dec 2021 | $1.44 M(-63.8%) | $1.44 M(-49.4%) |
| Sep 2021 | - | $2.85 M(-32.3%) |
| Jun 2021 | - | $4.21 M(-13.2%) |
| Mar 2021 | - | $4.85 M(+21.6%) |
| Dec 2020 | $3.99 M(+64.0%) | $3.99 M(+44.7%) |
| Sep 2020 | - | $2.76 M(-14.1%) |
| Jun 2020 | - | $3.21 M(+3.6%) |
| Mar 2020 | - | $3.10 M(+27.4%) |
| Dec 2019 | $2.43 M | $2.43 M(+16.0%) |
| Sep 2019 | - | $2.10 M(+12.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $1.87 M(+11.6%) |
| Mar 2019 | - | $1.68 M(+74.8%) |
| Dec 2018 | $959.00 K(-37.3%) | $959.00 K(-21.1%) |
| Sep 2018 | - | $1.22 M(-18.6%) |
| Jun 2018 | - | $1.49 M(+126.9%) |
| Mar 2018 | - | $658.00 K(-57.0%) |
| Dec 2017 | $1.53 M(+27.0%) | $1.53 M(-1.7%) |
| Sep 2017 | - | $1.56 M(+19.2%) |
| Jun 2017 | - | $1.30 M(-24.4%) |
| Mar 2017 | - | $1.73 M(+43.4%) |
| Dec 2016 | $1.20 M(+103.2%) | $1.20 M(+36.6%) |
| Sep 2016 | - | $881.30 K(-26.9%) |
| Jun 2016 | - | $1.21 M(+2.9%) |
| Mar 2016 | - | $1.17 M(+97.9%) |
| Dec 2015 | $592.40 K(-67.6%) | $592.40 K(+47.5%) |
| Sep 2015 | - | $401.70 K(-60.2%) |
| Jun 2015 | - | $1.01 M(-46.3%) |
| Mar 2015 | - | $1.88 M(+2.7%) |
| Dec 2014 | $1.83 M(+2370.6%) | $1.83 M(+29.3%) |
| Jun 2014 | - | $1.42 M(+273.5%) |
| Mar 2014 | - | $379.20 K |
| Dec 2013 | $74.10 K(+37.2%) | - |
| Dec 2012 | $54.00 K | - |
FAQ
- What is Viking Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Viking Therapeutics?
- What is Viking Therapeutics annual accounts payable year-on-year change?
- What is Viking Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Viking Therapeutics?
- What is Viking Therapeutics quarterly accounts payable year-on-year change?
What is Viking Therapeutics annual accounts payable?
The current annual accounts payable of VKTX is $9.81 M
What is the all time high annual accounts payable for Viking Therapeutics?
Viking Therapeutics all-time high annual accounts payable is $9.81 M
What is Viking Therapeutics annual accounts payable year-on-year change?
Over the past year, VKTX annual accounts payable has changed by +$2.30 M (+30.63%)
What is Viking Therapeutics quarterly accounts payable?
The current quarterly accounts payable of VKTX is $9.81 M
What is the all time high quarterly accounts payable for Viking Therapeutics?
Viking Therapeutics all-time high quarterly accounts payable is $11.09 M
What is Viking Therapeutics quarterly accounts payable year-on-year change?
Over the past year, VKTX quarterly accounts payable has changed by $0.00 (0.00%)